Evidence map›Paper›PMID 38597390›Full record

ArticleeLife2024

KIS counteracts PTBP2 and regulates alternative exon usage in neurons.

Marcos Moreno-Aguilera, Alba M Neher, Mónica B Mendoza, Martin Dodel, Faraz K Mardakheh, Raúl Ortiz, Carme Gallego

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marcos Moreno-Aguilera *Molecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5243-9582
Alba M Neher *Molecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain.
Mónica B MendozaMolecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain.
Martin DodelBarts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Faraz K MardakhehBarts Cancer Institute, Queen Mary University of London, London, United Kingdom.ORCID https://orcid.org/0000-0003-3896-0827
Raúl OrtizMolecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain.
Carme GallegoMolecular Biology Institute of Barcelona (IBMB), CSIC, Barcelona, Spain.ORCID https://orcid.org/0000-0001-6961-3524
Institut de Biologia Molecular de Barcelona · ESQueen Mary University of London · GB

Funding

Medical Research Council MR/P009417/1
6 · The paper itself

Abstract

Alternative RNA splicing is an essential and dynamic process in neuronal differentiation and synapse maturation, and dysregulation of this process has been associated with neurodegenerative diseases. Recent studies have revealed the importance of RNA-binding proteins in the regulation of neuronal splicing programs. However, the molecular mechanisms involved in the control of these splicing regulators are still unclear. Here, we show that KIS, a kinase upregulated in the developmental brain, imposes a genome-wide alteration in exon usage during neuronal differentiation in mice. KIS contains a protein-recognition domain common to spliceosomal components and phosphorylates PTBP2, counteracting the role of this splicing factor in exon exclusion. At the molecular level, phosphorylation of unstructured domains within PTBP2 causes its dissociation from two co-regulators, Matrin3 and hnRNPM, and hinders the RNA-binding capability of the complex. Furthermore, KIS and PTBP2 display strong and opposing functional interactions in synaptic spine emergence and maturation. Taken together, our data uncover a post-translational control of splicing regulators that link transcriptional and alternative exon usage programs in neuronal development.

Indexed as

Alternative SplicingExonsNeuronsPolypyrimidine Tract-Binding ProteinProtein Serine-Threonine KinasesAnimalsHeterogeneous-Nuclear RibonucleoproteinsHumansIntracellular Signaling Peptides and ProteinsMiceNerve Tissue ProteinsPhosphorylationRNA-Binding ProteinsHeterogeneous-Nuclear RibonucleoproteinsIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsPolypyrimidine Tract-Binding ProteinProtein Serine-Threonine KinasesPTBP2 protein, humanPtbp2 protein, mouseRNA-Binding ProteinsUHMK1 protein, humanUhmk1 protein, mousealternative splicingcell biologyexon usageKIS kinasemouseneuronal differentiationneurosciencePTBP2RNA binding

Identifiers

PMID38597390
PMCPMC11045219
OpenAlexW4394692277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.